GlassScriptPhysician profile
David R Couillard
NPI 1457462319
$5,388.97
in general payments reported to CMS, 2019-2025
47 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $393 · 2021: $874 · 2022: $826 · 2023: $998 · 2024: $754 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,297 · Education: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.97 |
| Education | $459.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,469.93 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $517.28 | 2019-2025 | |
| Janssen Biotech, INC. | $457.16 | 2022-2025 | Erleada, Akeega, Balversa |
| Coloplast Corp | $392.65 | 2019-2024 | |
| 180 Medical, INC. | $333.53 | 2019-2025 | Cure Ultra Catheter, Cure Catheter |
| Abbvie INC. | $265.19 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $220.98 | 2019-2025 | |
| Myovant Sciences INC. | $188.41 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $172.96 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar Pharmaceuticals, INC. | $125.13 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $89.86 | 2022-2024 | Keytruda |
| Boston Scientific Corporation | $84.09 | 2019-2020 | |
| Ge Healthcare | $71.55 | 2022 | |
| Verity Pharmaceuticals INC. | $65.90 | 2025 | Trelstar |
| Laborie Medical Technologies Corp. | $62.05 | 2023-2025 | Urgent PC Neuromodulation System |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Couillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.